Baruch Harris

Baruch Harris has a diverse work experience in the biotechnology and pharmaceutical industries. Baruch is currently serving as the Chief Operating Officer at Pretzel Therapeutics, where they focus on developing therapies to reverse mitochondrial dysfunction. Prior to that, they worked at ROME Therapeutics as a Senior Advisor and held various roles in business development and operations. Additionally, they worked as an Independent Consultant at Biotechnology Business Consulting, providing consulting services. Baruch also served as a Senior Advisor in Business Development at Yumanity Therapeutics.

Harris has held leadership positions at Metera Pharmaceuticals as the Chief Operating Officer, where they successfully led the company in a turnaround situation and secured funding. Baruch also worked as the Senior Director of Corporate Development and Program Executive at FORUM Pharmaceuticals.

Before transitioning to the biotech industry, Harris worked at F-Prime Capital as a Venture Partner, where they invested in biopharmaceutical and healthcare companies. Baruch also served as the Acting CEO and Board Member at Entrega Inc., a portfolio company of Enlight Biosciences, and as the Chief Business Officer at Enlight Biosciences itself, a venture creation firm.

Baruch'searly career includes roles at PureTech Health, where they founded and managed life sciences companies, and Novartis, where they held strategic planning and business operations positions.

Overall, Harris has extensive experience in leadership, business development, and strategic planning within the biotech and pharmaceutical sectors.

Baruch Harris attended Hollis-Brookline High School from 1987 to 1991, earning no degree or specializing in any particular field of study. Afterwards, from 1991 to 1995, Harris enrolled at Brown University where they obtained a ScB degree in Biophysics. Subsequently, Harris pursued further education at the University of California, San Francisco between 1998 and 2003. Baruch completed their education there with a PhD in the field of Biochemistry & Molecular Biology.